Appropriate design of prospective studies.
Publication
, Journal Article
Choi, J-H; Jung, S-H
Published in: J Clin Oncol
February 1, 2013
Duke Scholars
Published In
J Clin Oncol
DOI
EISSN
1527-7755
Publication Date
February 1, 2013
Volume
31
Issue
4
Start / End Page
510 / 511
Location
United States
Related Subject Headings
- Receptor, erbB-2
- Receptor, ErbB-2
- Oncology & Carcinogenesis
- Humans
- Female
- Breast Neoplasms
- Aromatase Inhibitors
- Antineoplastic Combined Chemotherapy Protocols
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Choi, J.-H., & Jung, S.-H. (2013). Appropriate design of prospective studies. J Clin Oncol, 31(4), 510–511. https://doi.org/10.1200/JCO.2012.46.0980
Choi, Jung-Hye, and Sin-Ho Jung. “Appropriate design of prospective studies.” J Clin Oncol 31, no. 4 (February 1, 2013): 510–11. https://doi.org/10.1200/JCO.2012.46.0980.
Choi J-H, Jung S-H. Appropriate design of prospective studies. J Clin Oncol. 2013 Feb 1;31(4):510–1.
Choi, Jung-Hye, and Sin-Ho Jung. “Appropriate design of prospective studies.” J Clin Oncol, vol. 31, no. 4, Feb. 2013, pp. 510–11. Pubmed, doi:10.1200/JCO.2012.46.0980.
Choi J-H, Jung S-H. Appropriate design of prospective studies. J Clin Oncol. 2013 Feb 1;31(4):510–511.
Published In
J Clin Oncol
DOI
EISSN
1527-7755
Publication Date
February 1, 2013
Volume
31
Issue
4
Start / End Page
510 / 511
Location
United States
Related Subject Headings
- Receptor, erbB-2
- Receptor, ErbB-2
- Oncology & Carcinogenesis
- Humans
- Female
- Breast Neoplasms
- Aromatase Inhibitors
- Antineoplastic Combined Chemotherapy Protocols
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis